외용 진통제 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 치료 용도별, 유효 성분별, 유통 채널별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Topical Pain Relief Market Summary

The global topical pain relief market size was valued at USD 11.4 billion in 2025 and is projected to grow from USD 12.1 billion in 2026 to USD 18.8 billion by 2033, at a CAGR of 6.5% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 39.3% in 2025. The rising prevalence of musculoskeletal conditions, arthritis, and localized muscle and joint pain is increasing the need for convenient pain-management options.

Growing consumer preference for OTC and self-care treatments supports demand for topical creams, gels, patches, and roll-ons as non-invasive alternatives to oral medications. In addition, the expanding elderly population and participation in sports/physical activities are increasing the incidence of joint pain, muscle soreness, sprains, and other localized conditions, further supporting market growth.

The rising prevalence of chronic pain is increasing demand for topical pain-relief products, including creams, gels, patches, and sprays, as patients seek convenient options to manage persistent discomfort. The growing incidence of back pain, neuropathic pain, and other long-term pain conditions is expanding the use of localized therapies, particularly for patients seeking alternatives to oral medications.

The rising prevalence of musculoskeletal disorders and arthritis is driving demand for topical pain relief such as creams, gels, patches, and sprays. Increasing joint pain, stiffness, and localized inflammation, particularly among aging populations, is encouraging patients to use convenient topical therapies for targeted symptom relief. Growing preference for non-invasive, self-administered pain management is further supporting market adoption.

Global Topical Pain Relief Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global topical pain relief market report based on the product, therapeutic application, active ingredients, distribution channel, end use, and region:

• Product Outlook (Revenue, USD Billion, 2021 - 2033)
• Gels
• Ointments
• Roll-ons
• Sprays
• Creams
• Patches
• Others
• Therapeutic Application Outlook (Revenue, USD Billion, 2021 - 2033)
• Arthritis & Joint Pain
• Muscle Pain & Strains
• Back & Neck Pain
• Neuropathic Pain
• Bruises & Minor Injuries
• Sports Injuries
• Active Ingredients Outlook (Revenue, USD Billion, 2021 - 2033)
• NSAIDs
  • Diclofenac
  • Ibuprofen
  • Ketoprofen
  • Piroxicam
  • Others
• Counterirritants / Rubefacients
  • Menthol
  • Camphor
  • Methyl Salicylate
  • Others
• Capsaicinoids
  • Capsaicin
  • Capsicum Oleoresin
• Local Anesthetics
  • Lidocaine
  • Benzocaine & Others
• Other Active Ingredients
  • Herbal formulations
  • CBD (where applicable)
  • Combination formulations
• Distribution Channel Outlook (Revenue, USD Billion, 2021 - 2033)
• Hospital Pharmacies
• Retail Pharmacies & Drug Stores
• Online Pharmacies & E-Commerce Platforms
• Supermarkets / Mass Merchandisers
• Others
• End Use Outlook (Revenue, USD Billion, 2021 - 2033)
• Homecare
• Hospitals
• Clinics
• Sports & Fitness Facilities
• Rehabilitation & Physiotherapy Centers
• Sports Medicine Centers
• Other Healthcare Settings
• Regional Outlook (Revenue, USD Billion, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Product
  • 1.1.2. Therapeutic Application
  • 1.1.3. Active Ingredients
  • 1.1.4. Distribution Channel
  • 1.1.5. End Use
  • 1.1.6. Regional Scope
  • 1.1.7. Estimates and Forecast Timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
• 1.5. Details of primary research
  • 1.5.1. Data for primary interviews in North America
  • 1.5.2. Data for primary interviews in Europe
  • 1.5.3. Data for primary interviews in Asia Pacific
  • 1.5.4. Data for primary interviews in Latin America
  • 1.5.5. Data for Primary interviews in MEA
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.1.1. Approach 1: Commodity flow approach
  • 1.7.2. Volume price analysis (Model 2)
    • 1.7.2.1. Approach 2: Volume price analysis
• 1.8. Research Scope and Assumptions
  • 1.8.1. List of Secondary Sources
  • 1.8.2. List of Primary Sources
  • 1.8.3. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Topical Pain Relief Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
    • 3.2.1.1. Rising prevalence of chronic and musculoskeletal pain
    • 3.2.1.2. Preference for localized pain management
    • 3.2.1.3. Increasing OTC self-medication and convenience
    • 3.2.1.4. Growing aging population
  • 3.2.2. Market Restraints Analysis
    • 3.2.2.1. Product-related skin irritation and adverse reactions
    • 3.2.2.2. Competition from oral analgesics and alternative therapies
  • 3.2.3. Market Opportunity Analysis
    • 3.2.3.1. Development of advanced drug-delivery formulations
    • 3.2.3.2. Expansion of sports and active-lifestyle pain products
    • 3.2.3.3. Growth of natural and botanical formulations
    • 3.2.3.4. Expansion through e-commerce and digital health channels
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Regulatory requirements and formulation compliance
    • 3.2.4.2. Strong price competition and product commoditization
• 3.3. Topical Pain Relief Market Analysis Tools
  • 3.3.1. Porter's Analysis
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal landscape

Chapter 4. Topical Pain Relief Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Topical Pain Relief Market: Product Movement Analysis, 2025 & 2033 (USD Billion)
• 4.3. Global Topical Pain Relief Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Billion)
  • 4.3.1. Gels
    • 4.3.1.1. Gels market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 4.3.2. Ointments
    • 4.3.2.1. Ointments market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 4.3.3. Roll-ons
    • 4.3.3.1. Roll-ons market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 4.3.4. Sprays
    • 4.3.4.1. Sprays market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 4.3.5. Creams
    • 4.3.5.1. Creams market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 4.3.6. Patches
    • 4.3.6.1. Patches market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 4.3.7. Others
    • 4.3.7.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 5. Topical Pain Relief Market: Therapeutic Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Topical Pain Relief Market: Therapeutic Application Movement Analysis, 2025 & 2033 (USD Billion)
• 5.3. Global Topical Pain Relief Market Size & Trend Analysis, by Therapeutic Application, 2021 to 2033 (USD Billion)
  • 5.3.1. Arthritis & Joint Pain
    • 5.3.1.1. Arthritis & joint pain market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 5.3.2. Muscle Pain & Strains
    • 5.3.2.1. Muscle pain & strains market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 5.3.3. Back & Neck Pain
    • 5.3.3.1. Back & neck pain market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 5.3.4. Neuropathic Pain
    • 5.3.4.1. Neuropathic pain market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 5.3.5. Bruises & Minor Injuries
    • 5.3.5.1. Bruises & minor injuries market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 5.3.6. Sports Injuries
    • 5.3.6.1. Sports injuries market revenue estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 6. Topical Pain Relief Market: Active Ingredients Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Topical Pain Relief Market: Active Ingredients Movement Analysis, 2025 & 2033 (USD Billion)
• 6.3. Global Topical Pain Relief Market Size & Trend Analysis, by Active Ingredients, 2021 to 2033 (USD Billion)
  • 6.3.1. NSAIDs
    • 6.3.1.1. NSAIDs market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
    • 6.3.1.2. Diclofenac
      • 6.3.1.2.1. Diclofenac market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
    • 6.3.1.3. Ibuprofen
      • 6.3.1.3.1. Ibuprofen market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
    • 6.3.1.4. Ketoprofen
      • 6.3.1.4.1. Ketoprofen market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
    • 6.3.1.5. Piroxicam
      • 6.3.1.5.1. Piroxicam market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
    • 6.3.1.6. Others
      • 6.3.1.6.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 6.3.2. Counterirritants / Rubefacients
    • 6.3.2.1. Counterirritants / rubefacients market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
    • 6.3.2.2. Menthol
      • 6.3.2.2.1. Menthol market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
    • 6.3.2.3. Camphor
      • 6.3.2.3.1. Camphor market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
    • 6.3.2.4. Methyl Salicylate
      • 6.3.2.4.1. Methyl salicylate market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
    • 6.3.2.5. Others
      • 6.3.2.5.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 6.3.3. Capsaicinoids
    • 6.3.3.1. Capsaicinoids market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
    • 6.3.3.2. Capsaicin
      • 6.3.3.2.1. Capsaicin market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
    • 6.3.3.3. Capsicum Oleoresin
      • 6.3.3.3.1. Capsicum oleoresin market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 6.3.4. Local Anesthetics
    • 6.3.4.1. Local anesthetics market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
    • 6.3.4.2. Lidocaine
      • 6.3.4.2.1. Lidocaine market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
    • 6.3.4.3. Benzocaine & Others
      • 6.3.4.3.1. Benzocaine & others market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 6.3.5. Other Active Ingredients
    • 6.3.5.1. Other Active Ingredients market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
    • 6.3.5.2. Herbal Formulations
      • 6.3.5.2.1. Herbal formulations market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
    • 6.3.5.3. CBD
      • 6.3.5.3.1. CBD market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
    • 6.3.5.4. Combination Formulations
      • 6.3.5.4.1. Combination formulations market revenue estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 7. Topical Pain Relief Market: Distribution Channel Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Topical Pain Relief Market: Distribution Channel Movement Analysis, 2025 & 2033 (USD Billion)
• 7.3. Global Topical Pain Relief Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Billion)
  • 7.3.1. Hospital Pharmacies
    • 7.3.1.1. Hospital Pharmacies market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.3.2. Retail Pharmacies & Drug Stores
    • 7.3.2.1. Retail pharmacies & drug stores market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.3.3. Online Pharmacies & E-Commerce Platforms
    • 7.3.3.1. Online pharmacies & e-commerce platforms market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.3.4. Supermarkets / Mass Merchandisers
    • 7.3.4.1. Supermarkets / mass merchandisers market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 7.3.5. Others
    • 7.3.5.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 8. Topical Pain Relief Market: End Use Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Global Topical Pain Relief Market: End Use Movement Analysis, 2025 & 2033 (USD Billion)
• 8.3. Global Topical Pain Relief Market Size & Trend Analysis, by End Use 2021 to 2033 (USD Billion)
  • 8.3.1. Homecare
    • 8.3.1.1. Homecare market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 8.3.2. Hospitals
    • 8.3.2.1. Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 8.3.3. Clinics
    • 8.3.3.1. Clinics market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 8.3.4. Sports & Fitness Facilities
    • 8.3.4.1. Sports & fitness facilities market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 8.3.5. Rehabilitation & Physiotherapy Centers
    • 8.3.5.1. Rehabilitation & physiotherapy centers market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 8.3.6. Sports medicine centers
    • 8.3.6.1. Sports Medicine Centers market revenue estimates and forecasts, 2021 - 2033 (USD Billion)
  • 8.3.7. Other Healthcare Settings
    • 8.3.7.1. Other healthcare settings market revenue estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 9. Topical Pain Relief Market: Regional Estimates & Trend Analysis by Product, Therapeutic Application, Active Ingredients, Distribution Channel and End Use

• 9.1. Regional Dashboard
• 9.2. Market Size and Trend Analysis, 2021 to 2033
• 9.3. North America
  • 9.3.1. North America topical pain relief market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.3.2. U.S.
    • 9.3.2.1. Key country dynamics
    • 9.3.2.2. Competitive scenario
    • 9.3.2.3. Regulatory framework
    • 9.3.2.4. Reimbursement scenario
    • 9.3.2.5. U.S. topical pain relief market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.3.3. Canada
    • 9.3.3.1. Key country dynamics
    • 9.3.3.2. Competitive scenario
    • 9.3.3.3. Regulatory framework
    • 9.3.3.4. Reimbursement scenario
    • 9.3.3.5. Canada topical pain relief market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.3.4. Mexico
    • 9.3.4.1. Key country dynamics
    • 9.3.4.2. Competitive scenario
    • 9.3.4.3. Regulatory framework
    • 9.3.4.4. Reimbursement scenario
    • 9.3.4.5. Mexico topical pain relief market estimates and forecasts, 2021 - 2033 (USD Billion)
• 9.4. Europe
  • 9.4.1. Europe topical pain relief market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.4.2. UK
    • 9.4.2.1. Key country dynamics
    • 9.4.2.2. Competitive scenario
    • 9.4.2.3. Regulatory framework
    • 9.4.2.4. Reimbursement scenario
    • 9.4.2.5. UK topical pain relief market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.4.3. Germany
    • 9.4.3.1. Key country dynamics
    • 9.4.3.2. Competitive scenario
    • 9.4.3.3. Regulatory framework
    • 9.4.3.4. Reimbursement scenario
    • 9.4.3.5. Germany topical pain relief market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.4.4. France
    • 9.4.4.1. Key country dynamics
    • 9.4.4.2. Competitive scenario
    • 9.4.4.3. Regulatory framework
    • 9.4.4.4. Reimbursement scenario
    • 9.4.4.5. France topical pain relief market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.4.5. Italy
    • 9.4.5.1. Key country dynamics
    • 9.4.5.2. Competitive scenario
    • 9.4.5.3. Regulatory framework
    • 9.4.5.4. Reimbursement scenario
    • 9.4.5.5. Italy topical pain relief market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.4.6. Spain
    • 9.4.6.1. Key country dynamics
    • 9.4.6.2. Competitive scenario
    • 9.4.6.3. Regulatory framework
    • 9.4.6.4. Reimbursement scenario
    • 9.4.6.5. Spain topical pain relief market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.4.7. Sweden
    • 9.4.7.1. Key country dynamics
    • 9.4.7.2. Competitive scenario
    • 9.4.7.3. Regulatory framework
    • 9.4.7.4. Reimbursement scenario
    • 9.4.7.5. Sweden topical pain relief market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.4.8. Denmark
    • 9.4.8.1. Key country dynamics
    • 9.4.8.2. Competitive scenario
    • 9.4.8.3. Regulatory framework
    • 9.4.8.4. Reimbursement scenario
    • 9.4.8.5. Denmark topical pain relief market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.4.9. Norway
    • 9.4.9.1. Key country dynamics
    • 9.4.9.2. Competitive scenario
    • 9.4.9.3. Regulatory framework
    • 9.4.9.4. Reimbursement scenario
    • 9.4.9.5. Norway topical pain relief market estimates and forecasts, 2021 - 2033 (USD Billion)
• 9.5. Asia Pacific
  • 9.5.1. Asia Pacific topical pain relief market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.5.2. China
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Competitive scenario
    • 9.5.2.3. Regulatory framework
    • 9.5.2.4. Reimbursement scenario
    • 9.5.2.5. China topical pain relief market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.5.3. Japan
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Competitive scenario
    • 9.5.3.3. Regulatory framework
    • 9.5.3.4. Reimbursement scenario
    • 9.5.3.5. Japan topical pain relief market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.5.4. India
    • 9.5.4.1. Key country dynamics
    • 9.5.4.2. Competitive scenario
    • 9.5.4.3. Regulatory framework
    • 9.5.4.4. Reimbursement scenario
    • 9.5.4.5. India topical pain relief market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.5.5. South Korea
    • 9.5.5.1. Key country dynamics
    • 9.5.5.2. Competitive scenario
    • 9.5.5.3. Regulatory framework
    • 9.5.5.4. Reimbursement scenario
    • 9.5.5.5. South Korea topical pain relief market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.5.6. Australia
    • 9.5.6.1. Key country dynamics
    • 9.5.6.2. Competitive scenario
    • 9.5.6.3. Regulatory framework
    • 9.5.6.4. Reimbursement scenario
    • 9.5.6.5. Australia topical pain relief market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.5.7. Thailand
    • 9.5.7.1. Key country dynamics
    • 9.5.7.2. Competitive scenario
    • 9.5.7.3. Regulatory framework
    • 9.5.7.4. Reimbursement scenario
    • 9.5.7.5. Thailand topical pain relief market estimates and forecasts, 2021 - 2033 (USD Billion)
• 9.6. Latin America
  • 9.6.1. Latin America topical pain relief market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.6.2. Brazil
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Competitive scenario
    • 9.6.2.3. Regulatory framework
    • 9.6.2.4. Reimbursement scenario
    • 9.6.2.5. Brazil topical pain relief market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.6.3. Argentina
    • 9.6.3.1. Key country dynamics
    • 9.6.3.2. Competitive scenario
    • 9.6.3.3. Regulatory framework
    • 9.6.3.4. Reimbursement scenario
    • 9.6.3.5. Argentina topical pain relief market estimates and forecasts, 2021 - 2033 (USD Billion)
• 9.7. Middle East and Africa
  • 9.7.1. Middle East and Africa topical pain relief market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.7.2. South Africa
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Competitive scenario
    • 9.7.2.3. Regulatory framework
    • 9.7.2.4. Reimbursement scenario
    • 9.7.2.5. South Africa topical pain relief market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.7.3. Saudi Arabia
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Competitive scenario
    • 9.7.3.3. Regulatory framework
    • 9.7.3.4. Reimbursement scenario
    • 9.7.3.5. Saudi Arabia topical pain relief market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.7.4. UAE
    • 9.7.4.1. Key country dynamics
    • 9.7.4.2. Competitive scenario
    • 9.7.4.3. Regulatory framework
    • 9.7.4.4. Reimbursement scenario
    • 9.7.4.5. UAE topical pain relief market estimates and forecasts, 2021 - 2033 (USD Billion)
  • 9.7.5. Kuwait
    • 9.7.5.1. Key country dynamics
    • 9.7.5.2. Competitive scenario
    • 9.7.5.3. Regulatory framework
    • 9.7.5.4. Reimbursement scenario
    • 9.7.5.5. Kuwait topical pain relief market estimates and forecasts, 2021 - 2033 (USD Billion)

Chapter 10. Competitive Landscape

• 10.1. Recent Developments & Impact Analysis, Key Market Participants
• 10.2. Company Categorization
• 10.3. Company Market Share Analysis, 2025
• 10.4. Company Heat Map Analysis
• 10.5. Strategy Mapping
  • 10.5.1. Expansion
  • 10.5.2. Mergers & Acquisition
  • 10.5.3. Partnerships & Collaborations
  • 10.5.4. New Product Launches
  • 10.5.5. Research and Development
  • 10.5.6. Company Profiles
  • 10.5.7. AdvaCare Pharma
    • 10.5.7.1. Company overview
    • 10.5.7.2. Financial performance
    • 10.5.7.3. Product Benchmarking
    • 10.5.7.4. Strategic initiatives
  • 10.5.8. Bayer AG
    • 10.5.8.1. Company overview
    • 10.5.8.2. Financial performance
    • 10.5.8.3. Product Benchmarking
    • 10.5.8.4. Strategic initiatives
  • 10.5.9. Cipla Health Ltd.
    • 10.5.9.1. Company overview
    • 10.5.9.2. Financial performance
    • 10.5.9.3. Product Benchmarking
    • 10.5.9.4. Strategic initiatives
  • 10.5.10. Haleon
    • 10.5.10.1. Company overview
    • 10.5.10.2. Financial performance
    • 10.5.10.3. Product Benchmarking
    • 10.5.10.4. Strategic initiatives
  • 10.5.11. Kenvue Brands LLC. (Kimberly-Clark Corporation)
    • 10.5.11.1. Company overview
    • 10.5.11.2. Financial performance
    • 10.5.11.3. Product Benchmarking
    • 10.5.11.4. Strategic initiatives
  • 10.5.12. Hisamitsu Pharmaceutical Co.
    • 10.5.12.1. Company overview
    • 10.5.12.2. Financial performance
    • 10.5.12.3. Product Benchmarking
    • 10.5.12.4. Strategic initiatives
  • 10.5.13. The Procter & Gamble Company
    • 10.5.13.1. Company overview
    • 10.5.13.2. Financial performance
    • 10.5.13.3. Product Benchmarking
    • 10.5.13.4. Strategic initiatives
  • 10.5.14. Reckitt (Biofreeze)
    • 10.5.14.1. Company overview
    • 10.5.14.2. Financial performance
    • 10.5.14.3. Product Benchmarking
    • 10.5.14.4. Strategic initiatives